HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication.

Abstract
Argon plasma coagulation (APC) has been used to ablate Barrett's esophagus, however, its role in the management of non-dysplastic Barrett's esophagus is uncertain. The purpose of this study is to determine the efficacy of endoscopic argon plasma coagulation (APC) for ablation of Barrett's esophagus in a prospective randomized controlled trial in two university teaching hospitals. Fifty-seven patients using proton pump inhibitor (PPI) medication and with Barrett's esophagus were randomized to undergo either ablation using endoscopic argon plasma coagulation (APC) or ongoing surveillance. Fifty-one patients underwent endoscopy at 12 months. Endoscopic argon plasma coagulation (APC) versus surveillance endoscopy was studied. Endoscopy and histopathological appearances of Barrett's esophagus at 12 months follow-up was also studied. Initially, at least 95% ablation of the metaplastic mucosa was achieved in 25 of the 26 treated patients. At 12 months, 14 of 23 APC patients had at least 95% regression, and nine of 23 had complete regression of Barrett's esophagus. No surveillance patient had more than 95% regression. The length of Barrett's esophagus shortened significantly after APC (mean 3.0 vs. 0.5 cm). Significant regression of Barrett's esophagus follows ablation with APC, although complete regression was achieved in less than half. The role of APC ablation of non-dysplastic Barrett's esophagus remains uncertain.
AuthorsTim Bright, David I Watson, William Tam, Philip A Game, Roger Ackroyd, Peter G Devitt, Mark N Schoeman
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 54 Issue 12 Pg. 2606-11 (Dec 2009) ISSN: 1573-2568 [Electronic] United States
PMID19101798 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Copyright© Springer Science+Business Media, LLC 2008
Chemical References
  • Proton Pump Inhibitors
Topics
  • Adult
  • Aged
  • Argon Plasma Coagulation
  • Barrett Esophagus (drug therapy, pathology, surgery, therapy)
  • Esophagoscopy
  • Esophagus (drug effects, pathology, surgery)
  • Female
  • Hospitals, University
  • Humans
  • Male
  • Metaplasia
  • Middle Aged
  • Mucous Membrane (drug effects, pathology, surgery)
  • Prospective Studies
  • Proton Pump Inhibitors (therapeutic use)
  • South Australia
  • Time Factors
  • Treatment Outcome
  • Watchful Waiting

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: